Skip to Content

L 55 (Nevirapine Extended-Release 400 mg)

Pill with imprint L 55 is Yellow, Elliptical / Oval and has been identified as Nevirapine extended-release 400 mg. It is supplied by Aurobindo Pharma Limited.

Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L 55

Nevirapine extended-release

L 55
400 mg
Elliptical / Oval
Prescription only
Drug Class:
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Aurobindo Pharma Limited
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.